While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Alkermes plc (ALKS) re-initiated its earnings and revenue guidance for the full-year 2020. This guidance reflects the anticipated net impacts of the COVID-19 pandemic on Alkermes' operating and financial results.
from RTT - Earnings https://ift.tt/3gdjNIb
via IFTTT
No comments:
Post a Comment